243 related articles for article (PubMed ID: 36744264)
1. Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology.
Yang M; Yan Q; Luo Y; Wang B; Deng S; Luo H; Ye B; Wang X
Front Pharmacol; 2023; 14():1016967. PubMed ID: 36744264
[No Abstract] [Full Text] [Related]
2. Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
Li X; Zhou M; Chen W; Sun J; Zhao Y; Wang G; Wang B; Pan Y; Zhang J; Xu J
BMC Complement Med Ther; 2024 May; 24(1):208. PubMed ID: 38816744
[TBL] [Abstract][Full Text] [Related]
3. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
4. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
5. Study on the mechanism of action of
Yang AY; Liu HL; Yang YF
Front Pharmacol; 2022; 13():1072547. PubMed ID: 36699068
[No Abstract] [Full Text] [Related]
6. A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma.
Fan T; Chen X; Yang F; Li Y; Gao Q; Li S; Chen X; Chen X
J Clin Transl Res; 2023 Jun; 9(3):182-194. PubMed ID: 37275579
[TBL] [Abstract][Full Text] [Related]
7. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experiments.
Li S; Liu W; Wang TT; Chen TQ; Guo JC
Chem Biol Drug Des; 2024 Jan; 103(1):e14428. PubMed ID: 38230768
[TBL] [Abstract][Full Text] [Related]
8. Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking.
Bai YM; Liang S; Zhou B
Aging (Albany NY); 2024 Feb; 16(4):3773-3789. PubMed ID: 38364259
[TBL] [Abstract][Full Text] [Related]
9. Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments.
Zhu M; He Q; Wang Y; Duan L; Rong K; Wu Y; Ding Y; Mi Y; Ge X; Yang X; Yu Y
Front Pharmacol; 2023; 14():1238841. PubMed ID: 37900162
[No Abstract] [Full Text] [Related]
10. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
[TBL] [Abstract][Full Text] [Related]
11. Exploring the molecular mechanism of Artemisia rupestris L. for the treatment of hepatocellular carcinoma via PI3K/AKT pathway.
Zhang S; Cai X; Khan GJ; Cheng J; He J; Zhai K; Mao Y
J Ethnopharmacol; 2024 Mar; 322():117572. PubMed ID: 38097024
[TBL] [Abstract][Full Text] [Related]
12. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
[TBL] [Abstract][Full Text] [Related]
13. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Mechanisms Underlying the Hepatoprotective Effects of
Pan B; Pan W; Lu Z; Xia C
Evid Based Complement Alternat Med; 2021; 2021():5591402. PubMed ID: 34326886
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of Fu Fang Gang Liu liquid in treating condyloma acuminatum by network pharmacology and experimental validation.
Fan Z; Wang S; Xu C; Yang J; Cui B
BMC Complement Med Ther; 2023 Apr; 23(1):128. PubMed ID: 37081536
[TBL] [Abstract][Full Text] [Related]
16. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of the
Jiang N; Li H; Sun Y; Zeng J; Yang F; Kantawong F; Wu J
Front Pharmacol; 2021; 12():618522. PubMed ID: 33746755
[No Abstract] [Full Text] [Related]
18. Exploring the Molecular Targets and Therapeutic Potential of Coptisine in Colon Cancer: A Network Pharmacology Approach.
Yang J; Tao Q; Li J; Xie Y; Tang C; Huang X; Chen Y; Zeng C
Curr Med Chem; 2024 Jan; ():. PubMed ID: 38231070
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.
Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H
Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366
[TBL] [Abstract][Full Text] [Related]
20. Lobelia chinensis Lour inhibits the progression of hepatocellular carcinoma via the regulation of the PTEN/AKT signaling pathway in vivo and in vitro.
Luo J; Chen QX; Li P; Yu H; Yu L; Lu JL; Yin HZ; Huang BJ; Zhang SJ
J Ethnopharmacol; 2024 Jan; 318(Pt A):116886. PubMed ID: 37429502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
